{"data":{"id":1077,"citation":"Houghton PJ, Germain GS, Harwood FC, Schuetz JD, Stewart CF, Buchdunger E, Traxler P.: Imatinib mesylate is a potent inhibitor of the ABCG2 (BCRP) transporter and reverses resistance to topotecan and SN-38 in vitro. Cancer Res, Volume 64 (7), 2004","title":"Imatinib mesylate is a potent inhibitor of the ABCG2 (BCRP) transporter and reverses resistance to topotecan and SN-38 in vitro.","doi":"10.1158\/0008-5472.can-03-3344","doi_url":"https:\/\/doi.org\/10.1158\/0008-5472.can-03-3344","pmid":"15059881","pmid_url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/15059881\/","year":2004,"journal":"Cancer Res","volume":"64","issue":"7","page":"2333-2337","authors":[{"first_name":"Buchdunger E","last_name":null,"full_name":null},{"first_name":"Germain GS","last_name":null,"full_name":null},{"first_name":"Harwood FC","last_name":null,"full_name":null},{"first_name":"Houghton PJ","last_name":null,"full_name":null},{"first_name":"Schuetz JD","last_name":null,"full_name":null},{"first_name":"Stewart CF","last_name":null,"full_name":null},{"first_name":"Traxler P.","last_name":null,"full_name":null}],"url":"https:\/\/molmedb.upol.cz\/api\/v1\/publications\/1077","landing_page":"https:\/\/molmedb.upol.cz\/publication\/1077","created_at":"2021-01-20T08:40:14.000000Z","updated_at":null}}